Comparison of Cardiovascular Changes after Administration of Gadodiamide Injection and Gadopentetate Dimeglumine in Dogs

Academic Radiology

Volumn 4, Issue 3, 1997, Pages 204-209

  Bøkenes, Janny ^a   Hustvedt, Svein Olaf ^a   Refsum, Helge ^a,b  

^a NYCOMED IMAGING AS   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Contrast media, comparative studies; Electrocardiography (ECG); Gadolinium; Heart, MR

Indexed keywords

CONTRAST MEDIUM; DRUG DERIVATIVE; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; MEGLUMINE; ORGANOMETALLIC COMPOUND; PENTETIC ACID;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DOG; DRUG COMBINATION; DRUG EFFECT; FEMALE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE;

ANIMALS; CONTRAST MEDIA; DOGS; DRUG COMBINATIONS; FEMALE; GADOLINIUM; GADOLINIUM DTPA; HEMODYNAMIC PROCESSES; INJECTIONS, INTRAVENOUS; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID;

EID: 0031089891     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(05)80292-2     Document Type: Article

References (42)

1. Kashanian FK, Goldstein HA, Blumetti RF, Holyoak WL, Hugo FP, Dolker M. Rapid bolus injection of gadopentetate dimeglumine: absence of side effects in normal volunteers. AJNR 1990;11:853-856.
2. Niendorf HP, Alhassan A, Geens VR, Clauß W. Safety review of gadopentetate dimeglumine: extended clinical experience after more than five millon applications. Invest Radiol 1994;29(suppl 2):179-182.
3. deLange EE. Gadodiamide injection-enhanced MR imaging of the body: results of a multicenter trial. Acad Radiol 1994;1(suppl 1):23-29.
4. Wagoner MV, Worah D. Gadodiamide injection: first human experience with the nonionic magnetic resonance imaging enhancement agent. Invest Radiol 1993;28(suppl 1):44-48.
5. Sze G, Brant-Zawadzki M, Haughton VM, et al. Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology 1991;181:693-699.
6. Li HT, Saeed M, Wendland MF, Higgins CB. Responses after ionic and nonionic magnetic resonance contrast media in rats with acute myocardial infarction. Invest Radiol 1993;28:11-19.
7. Mühler A, Saeed M, Brasch RC, Higgins CB. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats. Radiology 1992;183: 523-528.
8. Mühler A, Saeed M, Brasch RC, Higgins CB. Amelioration of cardiodepressive effects of gadopentetate dimeglumine with addition of ionic calcium. Radiology 1992;184:159-164.
9. Masui T, Takehara Y, Aoshima R, Kaneko M. Acute hemodynamic effects of nonionic and ionic magnetic resonance contrast media in intravenous bolus injection in rats. Invest Radiol 1994;29(suppl 2):189-191.
10. Peters JL, Shaw DD. Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs. Acta Radiol 1993;34:1-7.
11. Takasuna K, Kasai Y, Kitano Y, et al. General pharmacological studies of the new non-ionic MRI contrast medium, DV-7572 injection. II. Respiratory and cardiovascular system, autonomic nervous system, digestive system, isolated organs and miscellaneous. Jpn Pharmacol Ther 1993;21(suppl):29-51.
12. Short CH, ed. Principles and practice of veterinary anesthesia. Baltimore, MD: Williams & Wilkins, 1987.
13. Sawyer DC, Lumb WV, Stone HL. Cardiovascular effects of halothane, methoxyflurane, pentobarbital, and thiamylal. J Appl Physiol 1971;30: 36-43.
14. Hotvedt R, Platou ES, Koppang ER, Refsum H. Pentobarbital plasma concentrations and cardiac electrophysiology during prolonged pentobarbital infusion anaesthesia in the dog. Acta Anaesth Scand 1982; 26:638-642.
15. Gordon PB, Lundby B. Gadodiamide injection (Omniscan) in paediatric patients examined for CNS or non-CNS indications: safety-tolerability-MRI efficacy. Proc Soc Med Reson/Eur Soc Magn Reson Med Biol 1995;3:1125.
16. Latchaw RE. Safety and efficacy of gadodiamide injection administered intravenously to children for contrast-enhanced MR of the central nervous system. Acad Radiol 1994;1(suppl 1):15-22.
17. Higgins CB, Schmidt W. Direct and reflex myocardial effects of intracoronary administered contrast materials in the anesthetized and conscious dog: comparison of standard and newer contrast materials. Invest Radiol 1978;13:205-216.
18. Higgins CB. Contrast media in the cardiovascular system. In: Sovak M, ed. Radiocontrast agents. Berlin, Germany: Springer-Verlag, 1984; 193-251.
19. Higgins CB, Sovak M, Schmidt WS, Kelley MJ, Newell JD. Direct myocardial effects of intracoronary administration of new contrast materials with low osmolality. Invest Radiol 1980;15:39-46.
20. Piao ZE, Murdock DK, Hwang MH, Gries W, Raymond RM, Scanlon PJ. Coronary angiography during acute myocardial infarction in dogs: comparison of the hemodynamic effects of ionic and nonionic contrast media. J Lab Clin Med 1988;112:319-323.
21. Fleetwood G, Bettmann MA, Gordon JL. The effects of radiographic contrast media on myocardial contractility and coronary resistance: osmolality, ionic concentration, and viscosity. Invest Radiol 1990;25:254-260.
22. Piao ZE, Murdock DK, Hwang MH, Raymond RM, Scanlon PJ. Hemodynamic abnormalities during coronary angiography: comparison of Hypaque-76, Hexabrix, and Omnipaque-350. Cath Cardiovasc Diagn 1989;16:149-154.
23. Weinmann HJ, Press WR, Gries H. Tolerance of extracellular contrast agents for magnetic resonance imaging. Invest Radiol 1990;25(suppl 1):49-50.
24. Sullivan ME, Goldstein HA, Sansone KJ, Stoner SA, Holyoak WL, Wiggins JR. Hemodynamic effects of Gd-DTPA administered via rapid bolus or slow infusion: a study in dogs. AJNR 1990;11:537-540.
25. Newell JD, Higgins CB, Kelley MJ, Green CE, Schmidt WS, Haigler F. The influence of hyperosmolality on left ventricular contractile state: disparate effects of nonionic and ionic solutions. Invest Radiol 1980; 15:363-370.
26. Akre BT, Dunkel JA, Hustvedt SO, Refsum H. Acute cardiotoxicity of gadolinium-based contrast media on the isolated rat heart. Acad Radiol (in press).
27. Drop LJ, Geffin GA, O'Keefe DD, et al. Relation between ionized calcium concentration and ventricular pump performance in the dog under hemodynamically controlled conditions. Am J Cardiol 1981;47:1041-1051.
28. Fischer HW, Morris TW. Possible factors in intravascular contrast media toxicity. Invest Radiol 1980;15(suppl 6):232-238.
29. Higgins CB, Schmidt W. Alterations in calcium levels of coronary sinus blood during coronary arteriography in the dog. Circulation 1978;58: 512-519.
30. Bourdillon PD, Bettmann MA, McCracken S, Poole-Wilson PA, Grossman W. Effects of a new nonionic and a conventional ionic contrast agent on coronary sinus ionized calcium and left ventricular hemodynamics in dogs. J Am Coll Cardiol 1985;6:845-853.
31. Trägårdh B, Almén T, Lynch P. Addition of calcium or other cations and of oxygen to ionic and non-ionic contrast media: effects on cardiac function during coronary arteriography. Invest Radiol 1975;10:231-238.
32. Matthai WH, Groh WC, Waxman HL, Kurnik PB. Adverse effects of calcium-binding contrast agents in diagnostic cardiac angiography: a comparison between formulations with and without calcium-binding additives. Invest Radiol 1995;30:663-668.
33. Niendorf HP, Brasch RC. Gd-DTPA tolerance and clinical safety. In: Brasch RC, Drayer BP, Haughton VM, Jinkins JR, Nelson LL, Sze G, eds. MRI contrast enhancement in the central nervous system: a case study approach. New York, NY: Raven, 1993;11-21.
34. ++ ratio in blood. Cardiovasc Intervent Radiol 1981;4:8-13.
35. Malécot CO, Feindt P, Trautwein W. Intracellular N-methyl-D-glucamine modifies the kinetics and voltage-dependence of the calcium current in guinea pig ventricular heart cells. Eur J Physiol 1988;411:235-242.
36. Chuck LHS, Refsum H, Rouleau JL, Mathey D, Sievers RE, Parmley WW. Direct pharmacologic and osmolal effects of contrast media on the mechanics of heart muscle isolated from cats. Am Heart J 1984; 108:97-104.
37. Okazaki O, Kurata T, Yoshioka N, Hakusui H. Pharmacokinetics and stability of caldiamide sodium in rats. Arzneimittel Forsch 1996;46:79-83.
38. Normann PT, Hals PA. In vivo stability and excretion of gadodiamide (Gd-DTPA BMA), a hydrophilic gadolinium complex used as a contrast-enhancing agent for magnetic resonance imaging. Eur J Drug Met Pharmacokin 1995;20:307-313.
39. Ekholm S, Jonsson E, Sandvik L, et al. Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous system. Acta Radiol 1996;37:223-228.
40. Jordan RM, Mintz RD. Fatal reaction to gadopentetate dimeglumine. AJR 1995;164:743-744.
41. Weiss KL. Severe anaphylactoid reaction after iv Gd-DTPA. Magn Reson Imaging 1990;8:817-818.
42. Tardy B, Guy C, Barral G, Page Y, Ollagnier M, Bertrand JC. Anaphylactic shock induced by intravenous gadopentetate dimeglumine (letter). Lancet 1992;339:494.